<table border="1" id="i24774d20-d624-4ce2-8055-8449b8a86588" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 1. PHARMACOKINETIC PARAMETERS FOR PREMARIN<sup>®</sup>
</caption>
<col width="140"></col>
<col width="200"></col>
<col width="124"></col>
<col width="85"></col>
<col width="65"></col>
<tbody>
<tr>
<td>Pharmacokinetic Profile of Unconjugated Estrogens 
Following a Dose of 1 x 0.625 mg</td>
</tr>
<tr>
<td>PK Parameter<br/>Arithmetic Mean <br/>(%CV)</td>
<td>C<sub>max</sub>
<br/>(pg/mL)</td>
<td>t<sub>max</sub>
<br/>(h)</td>
<td>t<sub>1/2</sub>
<br/>(h)</td>
<td>AUC<br/>(pg•h/mL)</td>
</tr>
<tr>
<td>Estrone</td>
<td>87 (33)</td>
<td>9.6 (33)</td>
<td>50.7 (35)</td>
<td>5557 (59)</td>
</tr>
<tr>
<td>Baseline-adjusted estrone</td>
<td>64 (42)</td>
<td>9.6 (33)</td>
<td>20.2 (40)</td>
<td>1723 (52)</td>
</tr>
<tr>
<td>Equilin</td>
<td>31 (38)</td>
<td>7.9 (32)</td>
<td>12.9 (112)</td>
<td>602 (54)</td>
</tr>
<tr>
<td>Pharmacokinetic Profile of Conjugated Estrogens 
Following a Dose of 1 x 0.625 mg</td>
</tr>
<tr>
<td>PK Parameter<br/>Arithmetic Mean <br/>(%CV)</td>
<td>C<sub>max</sub>
<br/>(ng/mL)</td>
<td>t<sub>max</sub>
<br/>(h)</td>
<td>t<sub>1/2</sub>
<br/>(h)</td>
<td>AUC<br/>(ng•h/mL)</td>
</tr>
<tr>
<td>Total Estrone</td>
<td>2.7 (43)</td>
<td>6.9 (25)</td>
<td>26.7 (33)</td>
<td>75 (52)</td>
</tr>
<tr>
<td>Baseline-adjusted total estrone</td>
<td>2.5 (45)</td>
<td>6.9 (25)</td>
<td>14.8 (35)</td>
<td>46 (48)</td>
</tr>
<tr>
<td>Total Equilin</td>
<td>1.8 (56)</td>
<td>5.6 (45)</td>
<td>11.4 (31)</td>
<td>27 (56)</td>
</tr>
<tr>
<td>Pharmacokinetic Profile of Unconjugated Estrogens 
Following a Dose of 1 x 1.25 mg</td>
</tr>
<tr>
<td>PK Parameter<br/>Arithmetic Mean <br/>(%CV)</td>
<td>C<sub>max</sub>
<br/>(pg/mL)</td>
<td>t<sub>max</sub>
<br/>(h)</td>
<td>t<sub>1/2</sub>
<br/>(h)</td>
<td>AUC<br/>(pg•h/mL)</td>
</tr>
<tr>
<td>Estrone</td>
<td>124 (30)</td>
<td>10.0 (32)</td>
<td>38.1 (37)</td>
<td>6332 (44)</td>
</tr>
<tr>
<td>Baseline-adjusted estrone</td>
<td>102 (35)</td>
<td>10.0 (32)</td>
<td>19.7 (48)</td>
<td>3159 (53)</td>
</tr>
<tr>
<td>Equilin</td>
<td>59 (43)</td>
<td>8.8 (36)</td>
<td>10.9 (47)</td>
<td>1182 (42)</td>
</tr>
<tr>
<td>Pharmacokinetic Profile of Conjugated Estrogens 
Following a Dose of 1 x 1.25 mg</td>
</tr>
<tr>
<td>PK Parameter<br/>Arithmetic Mean <br/>(%CV)</td>
<td>C<sub>max</sub>
<br/>(ng/mL)</td>
<td>t<sub>max</sub>
<br/>(h)</td>
<td>t<sub>1/2</sub>
<br/>(h)</td>
<td>AUC<br/>(ng•h/mL)</td>
</tr>
<tr>
<td>Total Estrone</td>
<td>4.5 (39)</td>
<td>8.2 (58)</td>
<td>26.5 (40)</td>
<td>109 (46)</td>
</tr>
<tr>
<td>Baseline-adjusted total estrone</td>
<td>4.3 (41)</td>
<td>8.2 (58)</td>
<td>17.5 (41)</td>
<td>87 (44)</td>
</tr>
<tr>
<td>Total equilin</td>
<td>2.9 (42)</td>
<td>6.8 (49)</td>
<td>12.5 (34)</td>
<td>48 (51)</td>
</tr>
</tbody>
</table>